Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients.

about

Less is more: reconsidering the need for regular use of diagnostic whole body radioiodine scintigraphy in the follow-up of differentiated thyroid cancer.

P2860

Q51155282-ECA904E9-F2E5-48CD-AFDE-08B1529338B4

P2860

Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients.

Item

http://www.wikidata.org/entity/Q38788305

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evaluation of 131I scintigraph ...... ive analysis of 1420 patients.

@en

type

Item

label

Evaluation of 131I scintigraph ...... ive analysis of 1420 patients.

@en

prefLabel

Evaluation of 131I scintigraph ...... ive analysis of 1420 patients.

@en

P1476

Evaluation of 131I scintigraph ...... ive analysis of 1420 patients.

@en

P2093

Burkhard Riemann

http://www.w3.org/2001/XMLSchema#string

Christian Wenning

http://www.w3.org/2001/XMLSchema#string

Frederik Anton Verburg

http://www.w3.org/2001/XMLSchema#string

Jose Manuel Gonzalez Carvalho

http://www.w3.org/2001/XMLSchema#string

Otmar Schober

http://www.w3.org/2001/XMLSchema#string

P2860

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature.

Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation.

Timing of post 131I ablation diagnostic whole body scan in differentiated thyroid cancer patients. Less than four months post ablation may be too early.

Long-term follow-up of patients with differentiated thyroid cancer who had negative 131I whole-body scan at first evaluation after treatment.

Peace of mind for patients with differentiated thyroid cancer?

No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer.

Differentiated thyroid cancer patients more than 60 years old paradoxically show an increased life expectancy.

P2888

s00259-016-3581-4

P304

744-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-016-3581-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dennis Görlich

Alexis Vrachimis

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27909769

http://www.w3.org/2001/XMLSchema#string

Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients.

about

P2860

P2860

Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698